Proteomics and genomics: perspectives on drug and target discovery

Genomics and proteomics technologies together with computational methods have led to powerful new strategies in basic and clinical research. It is useful to reflect on the success of these methods towards developing therapeutic strategies for human diseases. We focus in this issue on recent progress and innovations utilizing “omics” technologies to identify and validate drug targets, discover disease biomarkers, and design more effective drugs.